Here's what the headlines miss. Retatrutide isn't just stronger. It's structurally different. Semaglutide (Ozempic, Wegovy) hits one receptor: GLP 1. Tirzepatide (Mounjaro, Zepbound) hits two: GLP 1 and GIP. Retatrutide hits three by Great email from Hunter Williams today. Reta and Cagri : r Retatrutide Eli Lilly's Retatrutide: Gym Goers Are Taking Knock Offs Before Launch Business Insider Dozens of new obesity drugs are coming: these are the ones to watch Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP1, GIP, and Glucagon Agonists Khan 2026 Journal of Peptide Science Wiley Online Library Retatrutide, the next generation of GLP 1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late stage clinical trial, the company announced.